checkAd

    DGAP-News  357  0 Kommentare MediClin Continues to Grow Further - Seite 2



    Summary of the development of the Group and the Segments.



    Group sales in the amount of EUR 580.3 mill. increased compared to the previous year by EUR 25.0 mill. or 4.5 %. The post-acute segment contributed the largest share to sales growth of EUR 20.1 mill.



    The Group-EBIT rose from EUR 23.6 mill. to EUR 24.0 mill. The result attributable to shareholders of MediClin AG amounts to EUR 16.5 mill., same as in the 2015 financial year; earnings per share are EUR 0.35 (previous year: EUR 0.35).



    Development of the Segments



    Sales increased in the post-acute segment by EUR 20.1 mill. from EUR 330.9 mill. to EUR 351.0 mill. The clinics which offer exclusively rehabilitation services added to the sales plus as well as the clinics which offer additional medical services in acute neurology and acute psychosomatics in the scope of an integrated care concept. Sales in the acute segment improved by EUR 3.9 mill. from EUR 206.7 mill. to EUR 210.6 mill. and in the nursing care business area from EUR 14.1 mill. to EUR 14.7 mill. The post-acute segment result improved by EUR 4.6 mill. from EUR 13.9 mill. to EUR 18.5 mill., the segment EBIT-margin accounts for 5.3 %. The acute segment result reduced by EUR 2.9 mill. from EUR 8.7 mill. to EUR 5.8 mill. due to increased expenses. The segment EBIT-margin accounts for 2.8 %.



    MediClin is well positioned: Sound financial structure and stable results of operation



    The equity ratio is 52.3 %, and the net financial debt amounts to EUR 7.1 mill. In addition to cash and cash equivalents of EUR 41.6 mill. (previous year: EUR 29.5 mill.) the Group has sufficient credit lines to support capacity expansions in MediClin's medical focus areas as well as to generate additional sales.



    Hight investments secure growth



    In the 2016 financial year EUR 28.1 mill. (previous year: EUR 27.0 mill.) were invested in non-current assets (gross amount), including subsidies in the amount of EUR 6.4 mill. (previous year: EUR 2.7 mill.). EUR 18,5 mill. (previous year: EUR 16.7 mill.) was spent on maintenance and repair.

    Seite 2 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News MediClin Continues to Grow Further - Seite 2 DGAP-News: MediClin AG / Key word(s): Final Results MediClin Continues to Grow Further 30.03.2017 / 16:30 The issuer is solely responsible for the content of this announcement. MediClin Continues to Grow Further Offenburg, 30 March 2017 - The …